医療用ナノテクノロジー（ナノメディシン）の世界市場（～2026年）

• 英文タイトル：Global Healthcare Nanotechnology (Nanomedicine) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY12127 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は医療用ナノテクノロジー（ナノメディシン）のグローバル市場について調査・分析したレポートです。種類別（ナノメディシン、ナノ医療機器、ナノ診断、その他）市場規模、用途別（抗がん剤、CNS製品、抗感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療用ナノテクノロジー（ナノメディシン）の競争状況、市場シェア ・世界の医療用ナノテクノロジー（ナノメディシン）市場：種類別市場規模 2015年-2020年（ナノメディシン、ナノ医療機器、ナノ診断、その他） ・世界の医療用ナノテクノロジー（ナノメディシン）市場：種類別市場規模予測 2021年-2026年（ナノメディシン、ナノ医療機器、ナノ診断、その他） ・世界の医療用ナノテクノロジー（ナノメディシン）市場：用途別市場規模 2015年-2020年（抗がん剤、CNS製品、抗感染症、その他） ・世界の医療用ナノテクノロジー（ナノメディシン）市場：用途別市場規模予測 2021年-2026年（抗がん剤、CNS製品、抗感染症、その他） ・北米の医療用ナノテクノロジー（ナノメディシン）市場分析：米国、カナダ ・ヨーロッパの医療用ナノテクノロジー（ナノメディシン）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療用ナノテクノロジー（ナノメディシン）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療用ナノテクノロジー（ナノメディシン）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療用ナノテクノロジー（ナノメディシン）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amgen、Teva Pharmaceuticals、Abbott、UCB、Roche、Celgene、Sanofi、Merck & Co、Biogen、Stryker、Gilead Sciences、Pfizer、3M Company、Johnson & Johnson、SmitH& Nephew、Leadiant Biosciences、Kyowa Hakko Kirin、Takeda、Ipsen、Endo International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.

Market Analysis and Insights: Global Healthcare Nanotechnology (Nanomedicine) Market
The global Healthcare Nanotechnology (Nanomedicine) market size is projected to reach US$ 215130 million by 2026, from US$ 194920 million in 2020, at a CAGR of 9.6%% during 2021-2026.

Global Healthcare Nanotechnology (Nanomedicine) Scope and Market Size
Healthcare Nanotechnology (Nanomedicine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology (Nanomedicine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
SmitH& Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International

Market segment by Type, the product can be split into
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Market segment by Application, split into
Anticancer
CNS Product
Anti-infective
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Healthcare Nanotechnology (Nanomedicine) Revenue
1.4 Market by Type
1.4.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Nanomedicine
1.4.3 Nano Medical Devices
1.4.4 Nano Diagnosis
1.4.5 Other
1.5 Market by Application
1.5.1 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application: 2020 VS 2026
1.5.2 Anticancer
1.5.3 CNS Product
1.5.4 Anti-infective
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Perspective (2015-2026)
2.2 Global Healthcare Nanotechnology (Nanomedicine) Growth Trends by Regions
2.2.1 Healthcare Nanotechnology (Nanomedicine) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Healthcare Nanotechnology (Nanomedicine) Historic Market Share by Regions (2015-2020)
2.2.3 Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Healthcare Nanotechnology (Nanomedicine) Market Growth Strategy
2.3.6 Primary Interviews with Key Healthcare Nanotechnology (Nanomedicine) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Market Size
3.1.1 Global Top Healthcare Nanotechnology (Nanomedicine) Players by Revenue (2015-2020)
3.1.2 Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Players (2015-2020)
3.1.3 Global Healthcare Nanotechnology (Nanomedicine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio
3.2.1 Global Healthcare Nanotechnology (Nanomedicine) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Healthcare Nanotechnology (Nanomedicine) Revenue in 2019
3.3 Healthcare Nanotechnology (Nanomedicine) Key Players Head office and Area Served
3.4 Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
3.5 Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Healthcare Nanotechnology (Nanomedicine) Historic Market Size by Type (2015-2020)
4.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)
5.2 Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
6.2 Healthcare Nanotechnology (Nanomedicine) Key Players in North America (2019-2020)
6.3 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
6.4 North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
7.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Europe (2019-2020)
7.3 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
7.4 Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

8 China
8.1 China Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
8.2 Healthcare Nanotechnology (Nanomedicine) Key Players in China (2019-2020)
8.3 China Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
8.4 China Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
9.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Japan (2019-2020)
9.3 Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
9.4 Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
10.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
10.4 Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

11 India
11.1 India Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
11.2 Healthcare Nanotechnology (Nanomedicine) Key Players in India (2019-2020)
11.3 India Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
11.4 India Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size (2015-2020)
12.2 Healthcare Nanotechnology (Nanomedicine) Key Players in Central & South America (2019-2020)
12.3 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020)
12.4 Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview
13.1.3 Amgen Healthcare Nanotechnology (Nanomedicine) Introduction
13.1.4 Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Details
13.2.2 Teva Pharmaceuticals Business Overview
13.2.3 Teva Pharmaceuticals Healthcare Nanotechnology (Nanomedicine) Introduction
13.2.4 Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.2.5 Teva Pharmaceuticals Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Healthcare Nanotechnology (Nanomedicine) Introduction
13.3.4 Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 UCB
13.4.1 UCB Company Details
13.4.2 UCB Business Overview
13.4.3 UCB Healthcare Nanotechnology (Nanomedicine) Introduction
13.4.4 UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.4.5 UCB Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Healthcare Nanotechnology (Nanomedicine) Introduction
13.5.4 Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.5.5 Roche Recent Development
13.6 Celgene
13.6.1 Celgene Company Details
13.6.2 Celgene Business Overview
13.6.3 Celgene Healthcare Nanotechnology (Nanomedicine) Introduction
13.6.4 Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.6.5 Celgene Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Healthcare Nanotechnology (Nanomedicine) Introduction
13.7.4 Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.7.5 Sanofi Recent Development
13.8 Merck & Co
13.8.1 Merck & Co Company Details
13.8.2 Merck & Co Business Overview
13.8.3 Merck & Co Healthcare Nanotechnology (Nanomedicine) Introduction
13.8.4 Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.8.5 Merck & Co Recent Development
13.9 Biogen
13.9.1 Biogen Company Details
13.9.2 Biogen Business Overview
13.9.3 Biogen Healthcare Nanotechnology (Nanomedicine) Introduction
13.9.4 Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.9.5 Biogen Recent Development
13.10 Stryker
13.10.1 Stryker Company Details
13.10.2 Stryker Business Overview
13.10.3 Stryker Healthcare Nanotechnology (Nanomedicine) Introduction
13.10.4 Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
13.10.5 Stryker Recent Development
13.11 Gilead Sciences
10.11.1 Gilead Sciences Company Details
10.11.2 Gilead Sciences Business Overview
10.11.3 Gilead Sciences Healthcare Nanotechnology (Nanomedicine) Introduction
10.11.4 Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.11.5 Gilead Sciences Recent Development
13.12 Pfizer
10.12.1 Pfizer Company Details
10.12.2 Pfizer Business Overview
10.12.3 Pfizer Healthcare Nanotechnology (Nanomedicine) Introduction
10.12.4 Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.12.5 Pfizer Recent Development
13.13 3M Company
10.13.1 3M Company Company Details
10.13.2 3M Company Business Overview
10.13.3 3M Company Healthcare Nanotechnology (Nanomedicine) Introduction
10.13.4 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.13.5 3M Company Recent Development
13.14 Johnson & Johnson
10.14.1 Johnson & Johnson Company Details
10.14.2 Johnson & Johnson Business Overview
10.14.3 Johnson & Johnson Healthcare Nanotechnology (Nanomedicine) Introduction
10.14.4 Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.14.5 Johnson & Johnson Recent Development
13.15 SmitH& Nephew
10.15.1 SmitH& Nephew Company Details
10.15.2 SmitH& Nephew Business Overview
10.15.3 SmitH& Nephew Healthcare Nanotechnology (Nanomedicine) Introduction
10.15.4 SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.15.5 SmitH& Nephew Recent Development
13.16 Leadiant Biosciences
10.16.1 Leadiant Biosciences Company Details
10.16.2 Leadiant Biosciences Business Overview
10.16.3 Leadiant Biosciences Healthcare Nanotechnology (Nanomedicine) Introduction
10.16.4 Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.16.5 Leadiant Biosciences Recent Development
13.17 Kyowa Hakko Kirin
10.17.1 Kyowa Hakko Kirin Company Details
10.17.2 Kyowa Hakko Kirin Business Overview
10.17.3 Kyowa Hakko Kirin Healthcare Nanotechnology (Nanomedicine) Introduction
10.17.4 Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.17.5 Kyowa Hakko Kirin Recent Development
13.18 Takeda
10.18.1 Takeda Company Details
10.18.2 Takeda Business Overview
10.18.3 Takeda Healthcare Nanotechnology (Nanomedicine) Introduction
10.18.4 Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.18.5 Takeda Recent Development
13.19 Ipsen
10.19.1 Ipsen Company Details
10.19.2 Ipsen Business Overview
10.19.3 Ipsen Healthcare Nanotechnology (Nanomedicine) Introduction
10.19.4 Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.19.5 Ipsen Recent Development
13.20 Endo International
10.20.1 Endo International Company Details
10.20.2 Endo International Business Overview
10.20.3 Endo International Healthcare Nanotechnology (Nanomedicine) Introduction
10.20.4 Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020)
10.20.5 Endo International Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Healthcare Nanotechnology (Nanomedicine) Key Market Segments
Table 2. Key Players Covered: Ranking by Healthcare Nanotechnology (Nanomedicine) Revenue
Table 3. Ranking of Global Top Healthcare Nanotechnology (Nanomedicine) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nanomedicine
Table 6. Key Players of Nano Medical Devices
Table 7. Key Players of Nano Diagnosis
Table 8. Key Players of Other
Table 9. Global Healthcare Nanotechnology (Nanomedicine) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2015-2020)
Table 13. Global Healthcare Nanotechnology (Nanomedicine) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Healthcare Nanotechnology (Nanomedicine) Market Growth Strategy
Table 19. Main Points Interviewed from Key Healthcare Nanotechnology (Nanomedicine) Players
Table 20. Global Healthcare Nanotechnology (Nanomedicine) Revenue by Players (2015-2020) (Million US$)
Table 21. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players (2015-2020)
Table 22. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2019)
Table 23. Global Healthcare Nanotechnology (Nanomedicine) by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Healthcare Nanotechnology (Nanomedicine) Product Solution and Service
Table 26. Date of Enter into Healthcare Nanotechnology (Nanomedicine) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 29. Global Healthcare Nanotechnology (Nanomedicine) Market Size Share by Type (2015-2020)
Table 30. Global Healthcare Nanotechnology (Nanomedicine) Revenue Market Share by Type (2021-2026)
Table 31. Global Healthcare Nanotechnology (Nanomedicine) Market Size Share by Application (2015-2020)
Table 32. Global Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 33. Global Healthcare Nanotechnology (Nanomedicine) Market Size Share by Application (2021-2026)
Table 34. North America Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 36. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 37. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 38. North America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 39. North America Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 40. Europe Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 42. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 44. Europe Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 46. China Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 47. China Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 48. China Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 49. China Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 50. China Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 51. China Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 52. Japan Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 54. Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 56. Japan Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 60. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 62. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 64. India Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 65. India Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 66. India Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 67. India Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 68. India Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 69. India Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Healthcare Nanotechnology (Nanomedicine) Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Healthcare Nanotechnology (Nanomedicine) Market Share (2019-2020)
Table 72. Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Healthcare Nanotechnology (Nanomedicine) Market Share by Type (2015-2020)
Table 74. Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Healthcare Nanotechnology (Nanomedicine) Market Share by Application (2015-2020)
Table 76. Amgen Company Details
Table 77. Amgen Business Overview
Table 78. Amgen Product
Table 79. Amgen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 80. Amgen Recent Development
Table 81. Teva Pharmaceuticals Company Details
Table 82. Teva Pharmaceuticals Business Overview
Table 83. Teva Pharmaceuticals Product
Table 84. Teva Pharmaceuticals Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 85. Teva Pharmaceuticals Recent Development
Table 86. Abbott Company Details
Table 87. Abbott Business Overview
Table 88. Abbott Product
Table 89. Abbott Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 90. Abbott Recent Development
Table 91. UCB Company Details
Table 92. UCB Business Overview
Table 93. UCB Product
Table 94. UCB Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 95. UCB Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. Celgene Company Details
Table 102. Celgene Business Overview
Table 103. Celgene Product
Table 104. Celgene Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 105. Celgene Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Product
Table 109. Sanofi Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 110. Sanofi Recent Development
Table 111. Merck & Co Business Overview
Table 112. Merck & Co Product
Table 113. Merck & Co Company Details
Table 114. Merck & Co Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 115. Merck & Co Recent Development
Table 116. Biogen Company Details
Table 117. Biogen Business Overview
Table 118. Biogen Product
Table 119. Biogen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 120. Biogen Recent Development
Table 121. Stryker Company Details
Table 122. Stryker Business Overview
Table 123. Stryker Product
Table 124. Stryker Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 125. Stryker Recent Development
Table 126. Gilead Sciences Company Details
Table 127. Gilead Sciences Business Overview
Table 128. Gilead Sciences Product
Table 129. Gilead Sciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 130. Gilead Sciences Recent Development
Table 131. Pfizer Company Details
Table 132. Pfizer Business Overview
Table 133. Pfizer Product
Table 134. Pfizer Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 135. Pfizer Recent Development
Table 136. 3M Company Company Details
Table 137. 3M Company Business Overview
Table 138. 3M Company Product
Table 139. 3M Company Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 140. 3M Company Recent Development
Table 141. Johnson & Johnson Company Details
Table 142. Johnson & Johnson Business Overview
Table 143. Johnson & Johnson Product
Table 144. Johnson & Johnson Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 145. Johnson & Johnson Recent Development
Table 146. SmitH& Nephew Company Details
Table 147. SmitH& Nephew Business Overview
Table 148. SmitH& Nephew Product
Table 149. SmitH& Nephew Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 150. SmitH& Nephew Recent Development
Table 151. Leadiant Biosciences Company Details
Table 152. Leadiant Biosciences Business Overview
Table 153. Leadiant Biosciences Product
Table 154. Leadiant Biosciences Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 155. Leadiant Biosciences Recent Development
Table 156. Kyowa Hakko Kirin Company Details
Table 157. Kyowa Hakko Kirin Business Overview
Table 158. Kyowa Hakko Kirin Product
Table 159. Kyowa Hakko Kirin Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 160. Kyowa Hakko Kirin Recent Development
Table 161. Takeda Company Details
Table 162. Takeda Business Overview
Table 163. Takeda Product
Table 164. Takeda Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 165. Takeda Recent Development
Table 166. Ipsen Company Details
Table 167. Ipsen Business Overview
Table 168. Ipsen Product
Table 169. Ipsen Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 170. Ipsen Recent Development
Table 171. Endo International Company Details
Table 172. Endo International Business Overview
Table 173. Endo International Product
Table 174. Endo International Revenue in Healthcare Nanotechnology (Nanomedicine) Business (2015-2020) (Million US$)
Table 175. Endo International Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Type: 2020 VS 2026
Figure 2. Nanomedicine Features
Figure 3. Nano Medical Devices Features
Figure 4. Nano Diagnosis Features
Figure 5. Other Features
Figure 6. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Application: 2020 VS 2026
Figure 7. Anticancer Case Studies
Figure 8. CNS Product Case Studies
Figure 9. Anti-infective Case Studies
Figure 10. Other Case Studies
Figure 11. Healthcare Nanotechnology (Nanomedicine) Report Years Considered
Figure 12. Global Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions: 2020 VS 2026
Figure 14. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Healthcare Nanotechnology (Nanomedicine) Market Share by Players in 2019
Figure 17. Global Top Healthcare Nanotechnology (Nanomedicine) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare Nanotechnology (Nanomedicine) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Healthcare Nanotechnology (Nanomedicine) Revenue in 2019
Figure 19. North America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Healthcare Nanotechnology (Nanomedicine) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

---